Clinical Trials

150 enrolled

Breast

Breast Neoplasms, Carcinoma in Situ

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

15 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Phase 1/2 Completed

224 enrolled 15 charts

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT06263582 2025-08-19

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

12 enrolled 18 charts

GynecologicLymphoid

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphoma, Follicular

NCT03808818 2025-03-18

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

306 enrolled 20 charts

Carcinoma in Situ, Neoplasms, Recurrence, Smoking Cessation

NCT05085977 2025-01-27

ADVANCED-1

12 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT05085990 2025-01-27

ADVANCED-1

10 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT04387461 2024-09-25

CORE-001

Phase 2 Completed

35 enrolled

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT03268993 2023-04-07

Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Head and Neck Neoplasms, Hyperplasia

NCT02039388 2022-09-02

LUSTIC

Classical hematologyGynecologic

701 enrolled

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT04823871 2022-09-02

EHUD

406 enrolled

Phase EARLY_PHASE1 Completed

Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT03182959 2021-06-21

Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Head and Neck Neoplasms, Hyperplasia

NCT00402779 2020-04-21

Erlotinib Prevention of Oral Cancer (EPOC)

Phase 3 Completed

303 enrolled 11 charts

Carcinoma in Situ, Mouth Neoplasms

NCT01901991 2017-08-11

Localization of Nonpalpable Breast Lesions

410 enrolled

Breast

Breast Neoplasms, Carcinoma in Situ

NCT02217358 2016-09-08

Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions

150 enrolled

Recurrent respiratory papillomatosis, Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Hoarseness

NCT02397252 2016-08-17

CASSIS

1,225 enrolled

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT00406068 2016-07-28

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Phase 2/3 Completed

129 enrolled

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Mycobacterium Infections, Neoplasm Recurrence, Local

NCT01384864 2016-01-11

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

30 enrolled

Gastrointestinal

Barrett Esophagus, Carcinoma in Situ

NCT01192204 2015-08-14

Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention

Phase 1/2 Completed

41 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ

NCT01316874 2015-06-12

Bladder Cancer

Phase 2/3 Completed

90 enrolled

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT01731652 2015-02-10

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Phase 2 Completed

12 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT01924117 2013-08-16

HPV

129 enrolled

Carcinoma in Situ, Uterine Cervical Dysplasia, Neoplasms, Papillomavirus Infections

NCT00141531 2012-06-14

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Phase 2 Completed

53 enrolled